XML 19 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net (loss) income attributable to Prairie Operating Co. $ 109,017,000 $ (152,673,000) $ 35,683,000 $ (2,617,000) $ (43,656,000) $ 33,066,000  
Adjustments to reconcile net (loss) income attributable to Prairie Operating Co. to net cash provided by operating activities              
Depreciation, depletion, and amortization         32,919,000 14,386,000  
Abandonment and impairment of unproved properties 196,000   0   608,000 0  
Stock–based compensation         9,040,000 3,722,000  
Unrealized loss (gain) on derivatives (77,779,000)   (23,206,000)   85,104,000 (23,090,000)  
(Gain) loss on adjustment to fair value – financial instrument liabilities (48,233,000)   2,373,000   (16,382,000) 4,537,000  
Deferred income taxes 19,814,000   0   (18,580,000) 0  
Amortization of deferred financing costs         1,899,000 2,940,000  
Changes in operating assets and liabilities:              
Oil, natural gas, and NGL accrued revenue         (6,010,000) (43,699,000)  
Joint interest and other receivables         15,872,000 1,152,000  
Inventory, prepaid expenses, and other current assets         (531,000) (3,461,000)  
Accounts payable, accrued expenses, and other current liabilities         16,630,000 16,175,000  
Revenue, ad valorem, and production taxes payable         17,343,000 3,994,000  
Net cash provided by operating activities         94,256,000 9,722,000  
Cash flows from investing activities:              
Development of oil and natural gas properties         (132,563,000) (53,973,000)  
Other asset and leasehold purchases         (11,336,000) (950,000)  
Cash paid for Bayswater asset purchase, net of cash received         0 (467,461,000)  
Cash received from payment on note receivable         0 95,000  
Net cash used in investing activities         (143,899,000) (522,289,000)  
Cash flows from financing activities:              
Borrowings on the Credit Facility         134,000,000 359,000,000  
Repayments on the Credit Facility         (64,000,000) 0  
Debt issuance costs associated with the Credit Facility         (1,945,000) (15,670,000)  
Proceeds from the issuance of Common Stock         1,841,000 43,817,000  
Financing costs associated with the issuance of Common Stock         (46,000) (3,311,000)  
Proceeds from the issuance of Series F Preferred Stock         0 148,250,000  
Financing costs associated with the issuance of Series F Preferred Stock         0 (11,059,000)  
Redemption of Series F Preferred Stock         (18,999,000) 0  
Payments of the Subordinated Note – related party         0 (3,214,000)  
Proceeds from option exercises         40,000 633,000  
Treasury stock repurchased         (1,247,000) (418,000)  
Net cash provided by financing activities         49,644,000 518,028,000  
Net increase in cash and cash equivalents         1,000 5,461,000  
Cash and cash equivalents, beginning of the period   $ 20,000   $ 5,192,000 20,000 5,192,000 $ 5,192,000
Cash and cash equivalents, end of the period $ 21,000   $ 10,653,000   $ 21,000 $ 10,653,000 $ 20,000